Ulrike MD - CureVac NV Sr Officer
| 5CV Stock | EUR 2.53 0.10 3.80% |
Insider
Ulrike MD is Sr Officer of CureVac NV
| Age | 51 |
| Phone | 49 7071 9883 0 |
| Web | https://www.curevac.com |
CureVac NV Management Efficiency
The company has return on total asset (ROA) of (0.3424) % which means that it has lost $0.3424 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1851) %, meaning that it generated substantial loss on money invested by shareholders. CureVac NV's management efficiency ratios could be used to measure how well CureVac NV manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Stephen MD | Moderna | 47 | |
| Elizabeth Tallett | Moderna | 70 | |
| Stephen Berenson | Moderna | 58 | |
| Jesper Themsen | Ballard Power Systems | N/A | |
| Randall MacEwen | Ballard Power Systems | 54 | |
| Israel Ruiz | Moderna | 47 | |
| Sean Marett | BioNTech SE | 58 | |
| Kjell Bjornsen | Nel ASA | N/A | |
| John Reynders | Moderna | N/A | |
| Noubar Afeyan | Moderna | 60 | |
| Dennis Schulz | ITM Power Plc | N/A | |
| Hakon Volldal | Nel ASA | 47 | |
| Hans Hide | Nel ASA | N/A | |
| Juan Andres | Moderna | 58 | |
| Tracey Franklin | Moderna | 39 | |
| Anders Soreng | Nel ASA | N/A | |
| Nicolas Pocard | Ballard Power Systems | N/A | |
| Rebecca Markillie | ITM Power Plc | N/A | |
| Jerh Collins | Moderna | N/A | |
| James Mock | Moderna | 46 | |
| Ray Jordan | Moderna | N/A | |
Management Performance
| Return On Equity | -0.19 | |||
| Return On Asset | -0.34 |
CureVac NV Leadership Team
Elected by the shareholders, the CureVac NV's board of directors comprises two types of representatives: CureVac NV inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CureVac. The board's role is to monitor CureVac NV's management team and ensure that shareholders' interests are well served. CureVac NV's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CureVac NV's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pierre BSc, CFO MD | ||
| Ulrike MD, Sr Officer | ||
| Slavica StevanovicHeck, Head HR | ||
| Thorsten Schuller, Head Communications | ||
| Igor MSc, Chief Board | ||
| Antony Blanc, Chief MD | ||
| Malte Greune, Member COO | ||
| Sarah Fakih, VP Relations | ||
| LLM LLM, Member CEO | ||
| Marco LLM, G Counsel |
CureVac Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CureVac NV a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.19 | |||
| Return On Asset | -0.34 | |||
| Profit Margin | (1.26) % | |||
| Operating Margin | (7.27) % | |||
| Current Valuation | 792.23 M | |||
| Shares Outstanding | 221.98 M | |||
| Shares Owned By Insiders | 45.68 % | |||
| Shares Owned By Institutions | 19.07 % | |||
| Price To Book | 2.07 X | |||
| Price To Sales | 13.59 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CureVac Stock
When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in CureVac Stock please use our How to Invest in CureVac NV guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.